Real time Chiasma (CHMA) stock price quote, stock graph, news & analysis.

Chiasma, Inc. (CHMA) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. Chiasma (CHMA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. CHMA Chiasma, Inc. Common Stock. Data is currently not available. $6.31. 0.18 (2.94%) DATA AS OF May 20, 2020 3:21 PM ET. Latest News. Chiasma Inc (CHMA) Q1 2020 Earnings Call Transcript May 8, 2020. You can buy and sell Chiasma (CHMA) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. 1,387 people own Chiasma on Robinhood on July 24, 2020. CHMA Stock Analysis Overview . What this means: InvestorsObserver gives Chiasma Inc (CHMA) an overall rank of 44, which is below average. Chiasma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

Chiasma, Inc. Common Stock (CHMA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

May 17, 2020 · If Chiasma Inc.'s (NASDAQ:CHMA) Mycapssa is approved as an orphan drug by the FDA on or around June 26, 2020, as anticipated, as the first and only FDA approved oral therapy (or pill)

On Wednesday morning, Chiasma, Inc. (NASDAQ: CHMA) announced the pricing of a public offering of common stock and pre-funded warrants.

CHMA Stock Analysis Overview What this means: Chiasma Inc (CHMA) gets an Overall Rank of 52, which is an above average rank under InvestorsObserver'sstock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Chiasma (CHMA) Stock Plummets on Disappointing FDA Letter. By Rachel Graf. Apr 18, 2016 1:12 PM EDT. INVESTING. Chiasma plunges after FDA rejects application for growth disorder drug.